Overview
Christopher Mcmackin is a primary care provider, practicing in Internal Medicine in Lanham, Maryland. Dr. Mcmackin is rated as an Experienced provider by MediFind in the treatment of Mevalonate Kinase Deficiency. His top areas of expertise are Gonorrhea, Syphilis, Myelitis, and AIDS Dementia Complex. Dr. Mcmackin is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- MEDICARE SNP
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- HMO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
9470 Annapolis Rd, Suite 309, Lanham, MD 20706
Johns Hopkins Outpatient Center
Dr. Bimal H. Ashar is a Professor of Clinical Medicine at the Johns Hopkins University School of Medicine. He serves as the Interim Director of the Division of General Internal Medicine, Clinical Director of the Division of General Internal Medicine, and Director of the Executive & Preventive Health Program. Named one of the “Best Doctors in America”, Dr. Ashar’s primary research interests include preventive medicine, dietary supplements and medical education, and he has authored numerous book chapters and articles on these topics. Dr. Ashar is also an editor of The Johns Hopkins Internal Medicine Board Review book and a former consulting editor for the Medical Clinics of North America. Dr. Ashar is an active member of the Society of General Internal Medicine and has served as president for the mid-Atlantic region. He is also a fellow of the American College of Physicians. He obtained his medical degree from the University of Maryland School of Medicine. He completed his residency in internal medicine at Case Western Reserve University/University Hospitals of Cleveland. He subsequently became chief resident and a faculty member at Case Western. Dr. Ashar left Cleveland in 1998 and joined the faculty in the Division of General Internal Medicine at Johns Hopkins University. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida and has active medical licenses in Maryland and Washington, D.C.. Videos 2017 Excellence in Service and Professionalism Award - Bimal Ashar, M.D., The Johns Hopkins Hospital Recent News Articles and Media Coverage Young MDs Hazy on Dietary Supplements, Wall Street Journal, May 14, 2007. Dr. Ashar is rated as an Experienced provider by MediFind in the treatment of Mevalonate Kinase Deficiency. His top areas of expertise are Mevalonate Kinase Deficiency, Hypertension, Brugada Syndrome, and Postural Orthostatic Tachycardia Syndrome (POTS).
Janet Maynard is a primary care provider, practicing in Internal Medicine in Baltimore, Maryland. Dr. Maynard is rated as an Advanced provider by MediFind in the treatment of Mevalonate Kinase Deficiency. Her top areas of expertise are Gout, Atherosclerosis, Pompe Disease, and Arthritis.
Gevorg Sedrakyan is a primary care provider, practicing in Internal Medicine in Alexandria, Virginia. Dr. Sedrakyan is rated as a Distinguished provider by MediFind in the treatment of Mevalonate Kinase Deficiency. His top areas of expertise are Acute Cystitis, Cellulitis, Papular Urticaria, and Syphilis. Dr. Sedrakyan is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- AIDS Dementia ComplexDr. Mcmackin isAdvanced. Learn about AIDS Dementia Complex.
- AIDS Dysmorphic SyndromeDr. Mcmackin isAdvanced. Learn about AIDS Dysmorphic Syndrome.
- GonorrheaDr. Mcmackin isAdvanced. Learn about Gonorrhea.
- HIV/AIDSDr. Mcmackin isAdvanced. Learn about HIV/AIDS.
- MyelitisDr. Mcmackin isAdvanced. Learn about Myelitis.
- SyphilisDr. Mcmackin isAdvanced. Learn about Syphilis.
- Experienced
- AcneDr. Mcmackin isExperienced. Learn about Acne.
- Alopecia AreataDr. Mcmackin isExperienced. Learn about Alopecia Areata.
- Autosomal Recessive HypotrichosisDr. Mcmackin isExperienced. Learn about Autosomal Recessive Hypotrichosis.
- CellulitisDr. Mcmackin isExperienced. Learn about Cellulitis.
- Congenital Cardiovascular ShuntDr. Mcmackin isExperienced. Learn about Congenital Cardiovascular Shunt.
- COVID-19Dr. Mcmackin isExperienced. Learn about COVID-19.